TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that ...
The biggest piece of rocketry needed for the next Artemis mission is headed to Florida. While the base of the Space Launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results